Dr Genevieve Martin
Research Fellow
Department of Microbiology and Immunology
62 Scholarly works
2 Projects
HIGHLIGHTS
2026
Research grants (other domestic)
Understanding Drivers of Immunopathology in Flavivirus Encephalitis
2025
Journal article
High expression of interleukin-18 receptor alpha correlates with severe respiratory viral disease and defines T cells with reduced cytotoxic signatures
DOI: 10.1038/s41467-025-65262-52025
Journal article
Disease progression & treatment need in sub-genotype C4 hepatitis B infection: a retrospective cohort study in the Northern Territory, Australia
DOI: 10.1186/s12879-025-11213-w2025
Research grants (other domestic)
Identifying Host Immune Factors That Drive Severe Outcomes Across Multiple Viral Infections
2025
Journal article
Adverse reactions to trimethoprim/sulfamethoxazole for melioidosis eradication therapy: An evaluation of frequency and risk factors
DOI: 10.1016/j.ijid.2024.1072832024
Journal article
Is Respiratory Viral Infection an Inciting Event in the Development of Melioidosis? A Systematic Evaluation of Co-infection With Burkholderia pseudomallei and SARS-CoV-2 or Influenza
DOI: 10.1093/ofid/ofae7002024
Journal article
Estimation of the UV susceptibility of aerosolized SARS-CoV-2 to 254 nm irradiation using CFD-based room disinfection simulations.
DOI: 10.1038/s41598-024-63472-3
RECENT SCHOLARLY WORKS
2024
Journal article
Characterising HIV-1 transmission in Victoria, Australia: a molecular epidemiological study
DOI: 10.1016/j.lanwpc.2024.1011032024
Journal article
Rapid antiretroviral therapy in primary HIV-1 infection enhances immune recovery
DOI: 10.1097/QAD.00000000000038252024
Journal article
Non-SARS-CoV-2 respiratory viral detection and whole genome sequencing from COVID-19 rapid antigen test devices: a laboratory evaluation study
DOI: 10.1016/S2666-5247(23)00375-02023
Journal article
Real-time analysis of hospital length of stay in a mixed SARS-CoV-2 Omicron and Delta epidemic in New South Wales, Australia
DOI: 10.1186/s12879-022-07971-62023
Journal article
Laboratory evaluation of ELISA and indirect immunofluorescence assay in response to emergence of Japanese encephalitis virus genotype IV in Australia
DOI: 10.1016/j.jcv.2023.105580